NRx Pharmaceuticals (NRXP) Shares Up 40% on Heavy Volume, Following Positive COVID Data
Tweet
Share
E-mailGet Alerts NRXP Hot Sheet
Price: $3.00 --0%
Rating Summary:
3 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 9 | New: 12
Rating Summary:
3 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 9 | New: 12
Join SI Premium – FREE
NRx Pharmaceuticals (NASDAQ: NRXP) shares are gaining over 40% in the pre-market on heavy volume, following positive data, highlighting higher likelihood of surviving and recovering from critical COVID-19 in ZYESAMI patients previously administered Remdesivir.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Northwest Bancshares, Inc. (NWBI) PT Lowered to $10 at Piper Sandler
- Inflation relief has likely been delayed not destroyed - GS
- Solvay SA (SOLB:BB) (SOBS) PT Raised to EUR29 at Stifel
Create E-mail Alert Related Categories
Analyst Comments, FDA, Momentum Movers, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
